Video Experimental Relacionado

Updated: Jun 16, 2026

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities

Published on: October 2, 2018

Resolviendo el problema de plegamiento de la alfa-conotoxina: generación eficiente en resina dirigida por selenio de

Markus Muttenthaler¹, Simon T Nevin, Anton A Grishin

¹Institute for Molecular Bioscience, Division of Chemistry and Structural Biology, The University of Queensland, Brisbane, Queensland 4072, Australia.

Journal of the American Chemical Society

|February 19, 2010

Resumen

Los investigadores desarrollaron alfa-selenoconotoxinas utilizando la tecnología de la selenocisteína para mejorar la estabilidad y la potencia. Estos nuevos antagonistas nicotínicos son prometedores para nuevas terapias farmacológicas dirigidas a los receptores nicotínicos de acetilcolina (nAChR).

Área de la Ciencia:

La bioquímica es la bioquímica.
Química Medicinal La Química Medicinal es un campo de estudio de la química medicinal.
Biología Estructural Biología estructural.

Sus antecedentes:

Las alfa-conotoxinas son miniproteínas que antagonizan los receptores nicotínicos de acetilcolina (nAChR).
Lograr el plegamiento nativo y la estabilidad en las alfa-conotoxinas es crucial para las aplicaciones terapéuticas.
Los métodos existentes se enfrentan a desafíos en la producción eficiente de conotoxinas estables y funcionales.

Objetivo del estudio:

Desarrollar un nuevo método para producir alfa-conotoxinas con mayor estabilidad y potencia.
Para utilizar la selenocisteína en una síntesis de fase soportada para dirigir el plegamiento nativo.
Evaluar las propiedades biofísicas y el potencial terapéutico de las alfa-selenoconotoxinas.

Principales métodos:

El empleo de pares de selenocisteína en una resina anfifílica para reemplazar los pares de cisteína.
Utilizando un método de fase con soporte para dirigir el plegamiento nativo de las alfa-conotoxinas.
Caracterización de las alfa-selenoconotoxinas mediante cristalografía de rayos X y evaluación de su potencia en varios subtipos de nAChR.

Principales resultados:

Plegamiento nativo dirigido químicamente para las cinco subclases estructurales de las alfa-conotoxinas.
El análisis de rayos X confirmó la integridad del pliegue de la alfa-conotoxina y la naturaleza isosterica del enlace de diselenida.
Las alfa-selenoconotoxinas demostraron una potencia comparable o mejorada y una estabilidad mejorada contra la mezcla de enlaces disulfuro.

Conclusiones:

La tecnología de la selenocisteína permite la producción eficiente de alfa-conotoxinas estables con pliegues nativos.
Estos hallazgos apoyan el desarrollo de antagonistas nicotínicos potentes y estables para terapias farmacológicas.
Destaca la mayor aplicabilidad de la selenocisteína para péptidos y proteínas con enlaces disulfuro.

Más Videos Relacionados

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells

Published on: December 19, 2025

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Videos de Conceptos Relacionados

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...

Cholinergic Receptors: Nicotinic

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...